Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved endoscope for imaging and cell collection in the fallopian tubes.

Biophotonics discovery·2026
Same author

Tisotumab vedotin-associated Stevens-Johnson syndrome in a patient with recurrent vulvar cancer: Vulnerability and antibody drug conjugate toxicity considerations.

Gynecologic oncology reports·2026
Same author

Corded and hyalinized endometrioid carcinoma: A case report.

Case reports in women's health·2026
Same author

Challenges and Opportunities in the Treatment of Invasive Cervical Cancer in Low-Resource Settings: A Survey of the International Gynecologic Cancer Society Fellowship Programs.

JCO global oncology·2025
Same author

Synthesis and Characterization of Poly(Lactic-Co-Glycolic Acid)-Paclitaxel (PLGA-PTX) Nanoparticles Evaluated in Ovarian Cancer Models.

Pharmaceutics·2025
Same author

ACR Appropriateness Criteria® Ovarian Cancer Screening: 2024 Update.

Journal of the American College of Radiology : JACR·2025

Related Experiment Video

Updated: Jun 17, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Chemotherapy for gynecologic cancers.

Jamal Rahaman1, Norma Steiner, Monica Prasad Hayes

  • 1Mount Sinai School of Medicine, New York, NY, USA. jamal.rahaman@mssm.edu

The Mount Sinai Journal of Medicine, New York
|December 17, 2009
PubMed
Summary

This review details chemotherapy advancements for gynecologic cancers, including ovarian, endometrial, uterine sarcomas, gestational trophoblastic neoplasia, and cervical cancer. It explores current treatment strategies for various stages and types of these malignancies.

Related Experiment Videos

Last Updated: Jun 17, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Area of Science:

  • Gynecologic Oncology
  • Medical Oncology
  • Chemotherapy Research

Background:

  • Gynecologic malignancies represent a significant global health challenge.
  • Effective chemotherapy regimens are crucial for improving patient outcomes.
  • Recent advancements necessitate a comprehensive overview of current treatment landscapes.

Purpose of the Study:

  • To review recent developments and trends in chemotherapy for major gynecologic cancers.
  • To explore chemotherapeutic options across different stages (early, advanced, recurrent) and settings (adjuvant, neoadjuvant) for ovarian and uterine cancers.
  • To discuss treatment strategies for uterine sarcomas, gestational trophoblastic neoplasia, and cervical cancer.

Main Methods:

  • Systematic literature review of recent developments in gynecologic cancer chemotherapy.
  • Analysis of chemotherapeutic applications in ovarian, endometrial, uterine sarcoma, gestational trophoblastic neoplasia, and cervical cancers.
  • Discussion of treatment protocols based on disease stage, subtype, and prognostic scoring systems.

Main Results:

  • Chemotherapy plays a vital role in adjuvant, neoadjuvant, and recurrent settings for ovarian and uterine cancers.
  • Specific high-risk subtypes of uterine cancer benefit from adjuvant chemotherapy.
  • Chemotherapy is integral to managing gestational trophoblastic neoplasia and cervical cancer, including neoadjuvant and chemoradiation approaches.

Conclusions:

  • Chemotherapy remains a cornerstone in the multidisciplinary management of gynecologic malignancies.
  • Tailored chemotherapeutic strategies are essential for optimizing treatment efficacy across diverse gynecologic cancers.
  • Ongoing research continues to refine and advance chemotherapy protocols for improved patient survival and quality of life.